Cargando…

Erratum to: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models

Detalles Bibliográficos
Autores principales:	Chen, Jin-Shuen, Chang, Li-Chien, Wu, Chung-Ze, Tseng, Tzu-Ling, Lin, Jui-An, Lin, Yuh-Feng, Cheng, Chao-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516323/ https://www.ncbi.nlm.nih.gov/pubmed/28724378 http://dx.doi.org/10.1186/s12929-017-0348-6

Ejemplares similares

Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models
por: Chen, Jin-Shuen, et al.
Publicado: (2016)

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
por: Wu, Chung-Ze, et al.
Publicado: (2021)

Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis
por: Shuai, Tiankui, et al.
Publicado: (2019)

Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method
por: Winnicki, Wolfgang, et al.
Publicado: (2019)

Erratum to: Phosphotriesterase-related protein sensed albuminuria and conferred renal tubular cell activation in membranous nephropathy
por: Cheng, Chao-Wen, et al.
Publicado: (2016)

Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View
por: Kronbichler, Andreas, et al.
Publicado: (2016)

Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin
por: Hladunewich, Michelle A., et al.
Publicado: (2021)

Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis
por: Huang, Jing, et al.
Publicado: (2014)

Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus
por: Wu, Chung-Ze, et al.
Publicado: (2019)

Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007)

Pathophysiology of focal segmental glomerulosclerosis
por: Reidy, Kimberly, et al.
Publicado: (2007)

Pathogenesis of Focal Segmental Glomerulosclerosis
por: Lim, Beom Jin, et al.
Publicado: (2016)

Unwinding focal segmental glomerulosclerosis
por: Peev, Vasil, et al.
Publicado: (2017)

Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis
por: Kim, Jae Seok, et al.
Publicado: (2016)

Actinic Granuloma with Focal Segmental Glomerulosclerosis
por: Phasukthaworn, Ruedee, et al.
Publicado: (2016)

Alendronate-associated focal segmental glomerulosclerosis
por: Prikis, Marios, et al.
Publicado: (2009)

Interferon Induced Focal Segmental Glomerulosclerosis
por: Kayar, Yusuf, et al.
Publicado: (2016)

Focal Segmental Glomerulosclerosis in Waldenström's Macroglobulinemia
por: Batra, Akshee, et al.
Publicado: (2020)

Rituximab treatment of adults with primary focal segmental glomerulosclerosis
por: Wang, Liuwei, et al.
Publicado: (2023)

NPHS2 variation in focal and segmental glomerulosclerosis
por: Tonna, Stephen J, et al.
Publicado: (2008)

The Novel Diagnostic Biomarkers for Focal Segmental Glomerulosclerosis
por: Nafar, Mohsen, et al.
Publicado: (2014)

Multiple myeloma presenting with focal segmental glomerulosclerosis
por: Valizadeh, Nasim, et al.
Publicado: (2013)

Infection-Related Focal Segmental Glomerulosclerosis in Children
por: Dettmar, Anne Katrin, et al.
Publicado: (2016)

Complement Activation in Patients with Focal Segmental Glomerulosclerosis
por: Thurman, Joshua M., et al.
Publicado: (2015)

Focal Segmental Glomerulosclerosis: Genetics, Mechanism, and Therapies
por: Kronbichler, Andreas, et al.
Publicado: (2016)

Cytomegalovirus-induced collapsing focal segmental glomerulosclerosis
por: Grover, Vanya, et al.
Publicado: (2013)

Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis
por: Wen, Yumeng, et al.
Publicado: (2018)

Successful management of recurrent focal segmental glomerulosclerosis
por: Kienzl‐Wagner, Katrin, et al.
Publicado: (2018)

Bronchiectasis and Focal Segmental Glomerulosclerosis in Rheumatoid Arthritis
por: Chaudhuri, Arunabha D., et al.
Publicado: (2017)

Focal segmental glomerulosclerosis associated with mitochondrial disease
por: Lim, Kenneth, et al.
Publicado: (2017)

Focal segmental glomerulosclerosis associated with Good's syndrome
por: Yelken, Berna, et al.
Publicado: (2008)

Non-ischemic cardiomyopathy with focal segmental glomerulosclerosis
por: Kaur, Parminder, et al.
Publicado: (2020)

Collapsing Focal Segmental Glomerulosclerosis in Viral Infections
por: Muehlig, Anne K., et al.
Publicado: (2022)

Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis
por: de Cos, Marina, et al.
Publicado: (2022)

Focal Segmental Glomerulosclerosis Associated with Essential Thrombocythemia
por: Sugimoto, Hisashi, et al.
Publicado: (2022)

Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse
por: Troyanov, Stéphan, et al.
Publicado: (2023)

Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China
por: Guo, Shui-Ming, et al.
Publicado: (2015)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

Histological heterogeneity of glomerular segmental lesions in focal segmental glomerulosclerosis
por: Taneda, Sekiko, et al.
Publicado: (2011)

Focal segmental glomerulosclerosis – epidemiology aspects in children and adults
por: Hogg, Ronald, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_q6b4ra9gbra6ic5o0am1r87fih